BOLD

BOUNDLESS BIO INC

1.650

+0.450+37.50%

Opening10:40 04/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.460/1.200

TODAY RANGE1.405-1.680

VOL3.99M

MARKET CAP36.97M

52 WEEK RANGE0.9612-1.780

AVG VOL (3M)115.43K

% TURNOVER17.82%

TURNOVER--

P/E (TTM)-0.6340

% RANGE22.96%

EPS(TTM)-2.6027

P/E(FORWARD)-0.7051

P/B0.3748

BVPS4.403

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP32.76M

SHARES OUTSTANDING22.41M

NEXT EARNINGS05/07-05/11

FREE FLOAT19.86M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·16h ago
Boundless Bio Terminates Major Long-Term San Diego Lease
Seeking Alpha·03/20 07:25
Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader
Reuters·03/17 20:52
Boundless Bio to present oral kinesin degrader program at AACR Annual Meeting 2026
Reuters·03/17 20:52
BOUNDLESS BIO ANNOUNCES UPCOMING PRESENTATION OF ORAL KINESIN DEGRADER PROGRAM AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2026
TipRanks·03/10 11:17
Boundless Bio Inc. (BOLD) Receives a Hold from Guggenheim
Reuters·03/09 11:59
Boundless Bio Inc. publishes corporate presentation on ecDNA-directed cancer therapies and BBI-940 Phase 1 trial
TipRanks·03/09 11:06
Boundless Bio reports Q4 EPS (58c), consensus (52c)
TipRanks·03/09 11:06
Boundless Bio sees cash runway into 2H28
Seeking Alpha·03/09 11:06
Boundless Bio GAAP EPS of -$0.58 misses by $0.12
Reuters·03/09 11:03
Boundless Bio Q4 net loss narrows 22% to USD 12.89 million as R&D spending falls 26% to USD 9.82 million
Reuters·03/09 11:00
BOUNDLESS BIO INC - EXPECTS CASH TO FUND OPERATIONS INTO THE SECOND HALF OF 2028
Reuters·03/09 11:00
BOUNDLESS BIO INC - Q4 EPS $-0.58
Reuters·03/04 12:02
Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference
TipRanks·02/12 16:31
Boundless Bio Advances New Breast Cancer Drug BBI-940 Into First-in-Human Trial
Reuters·02/05 12:00
Boundless Bio CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat

Same Industry

Name/Symbol

Change%

Price

Regeneron Pharmaceuticals

REGN

-2.47%

748.87

GRDX

BNTX

United Therapeutics Corp.

UTHR

-0.53%

571.73

VRTX

SIGA

Moderna

MRNA

-0.62%

50.96

Charles Riv Labs Intl Inc

CRL

+0.06%

175.65

MEDP

Talphera Inc

TLPH

-6.35%

0.7606

ICON PLC

ICLR

+2.36%

112.97

CBPO

Iqvia Hldgs Inc

IQV

-0.97%

167.34

MOLN

ARCT

Gilead Sciences Inc

GILD

-2.18%

138.99

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-0.92%

96.07

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.